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ABSTRACT
Aim of the Study: Immediate breast reconstruction is often applied after mastectomy. However, inappropriate
surgical technique, postoperative radiotherapy and infection may lead to tissue necrosis and implant protrusion.
Traditional therapies frequently fail. However, previous data suggested that capsule flaps may be appropriate
for the salvage of implants. Our goal was to investigate the usefulness of capsuloplasty in patients with exposed
breast implant and to monitor the blood supply of capsule flaps during the operation. Materials and Methods:
Capsuloplasty was performed in 19 patients with exposed implant. After removal of necrotic tissue, capsulotomy
was performed, the planned flap was dissected free, the implant was covered with the flap and the wound was
then closed. During operation, the blood flow of the flap was determined by means of laser Doppler flowmetry.
Moreover, tissue samples were taken for histology and immunostaining for CD34. Results: The postoperative
follow-up showed that capsule flaps survived in each case: no complications were found. The blood flow of the
flaps did not change significantly during the intervention as compared with the baseline values. The histology
and the immunohistochemistry revealed considerable vascularization and angiogenesis in the flap. Conclusions:
Capsule flaps seem to be appropriate for the salvage of exposed implants and for enhancement of implant cover
in the case of thin and injured tissue.
Keywords: breast reconstruction; capsule flap; exposed implant; microcirculation; laser Doppler; angiogenesis
INTRODUCTION
Immediate one-stage breast reconstruction is becom-
ing a widely-accepted and preferred method. Implants
should be covered with tissue of appropriate thick-
ness and viability especially if patients receive post-5
mastectomy radiation therapy. It is known that
radiotherapy may be accompanied by a number of
complications1 including impaired wound healing,
wound separation, infection and fistula.2-4 These fac-
tors may lead to a considerable contraction of the10
capsule around the implant. This shrinking makes
the surface of the implant irregular which there-
fore exerts uneven pressure on the overlying skin.
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According to a hypothesis, the increased pressure
affecting such areas may impair the microcirculation 15
of the covering tissue layer potentially resulting in
necrosis and exposure of the implant.4 Inappropriate
surgical technique may also cause insufficient local
blood supply leading to necrosis and implant protru-
sion. Accompanying infection may contribute to this 20
process. Although exposed implants are traditionally
treated by insertion of a new one, many authors have
reported successful salvage of implant1-3 or alternative
therapeutic strategies.4-8 However, these interven-
tions may fail in cases of previous radiotherapy or 25
where tissue is injured or thin, necessitating implant
removal.
1
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For such cases, capsuloplasty seems to be an appro-
priate technique. The capsule appearing around the
implant is a reaction to foreign material.7,9 It con-30
sists of fibroblasts and collagen fibers, has own blood
supply and previous radiotherapy contributes to its
development.1 Bengston and coworkers described the
application of capsule flap decades ago. According
to their animal experiments, capsule flaps are viable35
and their vascular system is sufficient for the nutrition
of the overlying skin graft.10 In human, several areas
of use of capsule flap were reported e.g., prevention
of implant wrinkling,7,11 pharyngeal reconstruction,12
shaping of inframammary fold13 and cover for exposed40
implants.5-8 However, the blood flow in capsule
flaps has not yet been quantitatively determined
in vivo.
Thus, the goal of our present study was to investi-
gate the usefulness of capsuloplasty in patients with45
exposed breast implant and to monitor the blood sup-
ply of the capsule flaps during the operation.
MATERIALS AND METHODS
Patients
Capsuloplasty was performed in 19 females between50
January 2016 and November 2017. These patients
underwent earlier mastectomy and immediate breast
reconstruction. Their average age was 47.6 years
(range: 33–72 years). The right side was affected in
10 cases and the left side in 9 cases. 4 patients55
underwent bilateral mastectomy. Bilateral capsulo-
plasty was performed in 3 of these 4 patients, the
remaining 1 female underwent unilateral capsulo-
plasty (right side). Table 1 demonstrates the local-
ization of the defects indicating the operation. None60
of these patients received radiotherapy except 1
patient who underwent irradiation 1 year before
mastectomy.
Surgical Procedures
Each intervention was preceded by careful considera-65
tion of the following parameter: quality and thickness
of the breast skin, presence of inflammation, discharge
and fistula, previous radiotherapy, localization of tis-
sue damage, patient requirements and the extension
of necrosis and wound separation. The patients were 70
carefully observed in order to detect visible signs of
inflammation (erythema, edema). Moreover, leukocyte
number, C-reactive protein and procalcitonin levels
were also measured in each patient and samples were
taken for microbiological examination. Signs of serious 75
inflammation and large tissue defect were considered
exclusion criteria. However, in case of the involved
patients the mentioned parameters did not display ele-
vation and pathogenic bacteria were not found. (If cap-
sule flap is not feasible, the implant is to be removed 80
and delayed reconstruction with a flap e.g., latis-
simus flap or abdominal TRAM shall be performed.)
Figure 1A demonstrates a patient chosen for capsulo-
plasty. Apivotal point was the timing: the intervention
should not be performed sooner than an appropriate 85
capsule is formed around the implant. The tissue defect
in our patients appeared 8–13 weeks after the mas-
tectomy (median interval: 9 weeks). By this time, the
capsule around the implant was well-developed there-
fore it was appropriate to be used for reconstruction. 90
When the complication was recognized, the patients
started to be prepared for the reconstruction which
was performed within 3–5 days. During this period,
the defect was covered with sterile dressing. Periop-
erative antibiotic therapy was launched that involved 95
daily 1000 mg cefuroxime (2 × 500 mg) administered
orally. This therapy lasted 10–14 days. Another impor-
tant issue was the determination of the area from
which capsule can be gained for reconstruction. In 3
cases, an attempt was made to close the wound pri- 100
marily after removal of the necrotic tissue. The oper-
ation involved the following steps: after opening the
wound the necrotic partswere excised, the implantwas
removed and capsulotomy was performed, the base of
the flap remained intact, the planned flapwas then dis- 105
sected free (Figure 1B). After that, the implantwas posi-
tioned and covered with the capsule flap (Figure 1C).
Mentor’s Cohesive III implant with anatomical shape
and textured surface was applied. In most cases, new
implants were used. In a minority of the cases, when 110
the risk of infection and inflammation seemed to be
low, the same old implants were applied. If the wound
TABLE 1. Localization of the defects indicating the operation.
Side
Localization of the tissue defect Left Right
Wound separation in the scar of mastectomy 3 3
In the borderline of the inferior quadrants 2 4
In the inferior lateral quadrant 0 2
In the inferior medial quadrant 2 2
In the superior lateral quadrant 1 0
Journal of Investigative Surgery
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FIGURE 1. Photo documentation of the surgical intervention. A: A patient selected for capsu-
loplasty. B: The dissected capsule flap. C: The implant after positioning and covering with the
capsule flap. D: The closed wound. E: The healed wound 3 month after the operation.
was able to be closed tension free after application of
the capsule flap, the implant size was not reduced. If
the tension free wound closure seemed to have diffi-115
culties, a smaller implant was chosen. The wound was
closed with sutures (Figure 1D). Drainage was applied
when necessary. Various capsule flaps were applied:
anterior-superior medial, anterior-superior-lateral, in
1 case divided flap, and also posterior flaps from the120
chest wall. In 3 cases, thoraco-epigastrial fasciocuta-
neous flaps were used together with capsule flap in
order to complete the reconstruction due to a large
defect.
Patients were discharged on 3rd-5th postoperative125
day. An examination was performed 1 week after the
surgery. The second examination and removal of the
stitches were 1 week later. Following this, the patients
were examined monthly once (inspection and palpa-
tion of the operated site and the abovementioned labo-130
ratory examinations were performed, too). Ultrasound
imagingwas performed in every 3months (presence of
capsular contracture and peri-implant fluid).
Laser Doppler Flowmetry
Microcirculation of the flaps was monitored by means135
of the PeriFlux System 5000 (Perimed, Järfälla, Swe-
den). This equipment transmits low power laser light
(780 nm) to the tissue via a fiber optic probe. The return-
ing light is processed and the relative number and
velocity of the blood cells in the tissue are calculated140
and presented as blood perfusion. The sensorwas fixed
to the tissue with a sterile adhesive strip provided by
the manufacturer. Measurements were performed at 4
different time points: before the incision of the intact
capsule (baseline), after capsulotomy, after preparation145
of the capsule flap and after fixation of the flap. At
each time point, recordings were made for 5 minutes.
Perisoft for Windows software was used for data col-
lection, storage and analysis. The data are presented as
perfusion unit (P.U.). 150
Histology and Immunohistochemistry
During operation, biopsies were taken from the
capsule. Tissue samples were fixed in a buffered solu-
tion of formaldehyde (4%), embedded in paraffin
and 4-μm thick sections were taken. In addition to 155
routine haematoxylin-eosin staining, sections were
processed for immunohistochemical localization
to highlight CD34 positive vessel density. Primary
antibody to CD34 (clone QBEN/10 M7165; DAKO
Glostrup, Denmark) was used at 1:200 (20 min). Anti- 160
gen retrieval was performed by Bond Epitope Retrieval
solution 2 at pH = 9 by BOND MAX Autostainer
(Leica Biosystems, Newcastle Ltd., UK). Immuno-
sections were counterstained with conventional
haematoxylin. 165
Statistical Analysis
Data analysis was performed with SigmaStat for Win-
dows (Jandel Scientific, Erkrath, Germany). Since the
normality test (Shapiro-Wilk) failed in few cases,
nonparametric test was chosen. Friedman repeated- 170
measures analysis of variance on ranks was applied.
In the Figure and Results, median values (M) with
25th and 75th percentiles (25p and 75p, respec-
tively) are given, p < 0.05 was considered statistically
significant. 175
C© 2018 Taylor & Francis Group, LLC
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RESULTS
Attempts at the primary closure of wounds after
removal of necrotic tissue failed in the above men-
tioned 3 cases: the implants were exposed again. How-
ever, application of capsule flaps led to the healing180
of these patients without complication. Postopera-
tive follow-up (ranging from 2 months to 19 months)
showed that capsule flaps survived in each case. No
signs of inflammation, infection, hematoma, wound
separation and implant protrusion were found. Slight185
erythema was detected in 2 cases. In few cases, uneven
surface and wrinkling were detected. However, our
examinations excluded the capsular contracture and
all of these signs ceased within 3 months. Figure 1E
shows a patient in the 3rd postoperative month, a190
complete healing can be seen.
As concerns microcirculation of the flaps, the base-
line median value in capsule flaps was 98.97 P.U.
(25p = 73.56, 75p = 124.09). The perfusion in the
capsule did not change after the capsulotomy (M =195
106.96%, 25p = 62.82, 75p = 157.07) as referred to the
baseline values. Although a slight decrease was mea-
sured after preparation of the capsule (M = 64.08%,
25p= 33.36, 75p= 135.99) and fixation of the flap (M=
51.41%., 25p = 32.7, 75p = 96.99), this change was not200
statistically significant (Figure 2A).
The baseline values of the thoraco-epigastrial fascio-
cutaneous flaps: M = 14.87 P.U., 25p = 10.37, 75p =
32.15. No decrease was found in their blood after cap-
sulotomy (M= 95.56%, 25p= 48.14, 75p= 127.44), after205
preparation of the capsule (M = 120.27%, 25p = 45.32,
75p = 173.77) or after fixation of the flap (M = 62.52%,
25p = 31.58, 75p = 108.59) (Figure 2B).
Histological analysis revealed that capsules were
well-vascularized and several vessels were present in210
FIGURE 3. A: Low power micrograph of the capsule (haemat
oxylin-eosin staining, slide scanning, scale bar: 200μm). Perforat-
ing vessels in the connecting tissue between striated muscle and
capsule (dashed line). B: CD34-positive structures in the capsule
(immunohistochemistry for CD34, counterstaining with haema-
toxylin, CD34-positive parts appear brown).
the connective tissue which may provide sufficient
blood supply for the capsule (Figure 3A). Immunohis-
tochemistry confirmed this finding: the CD34-positive
structures demonstrated angiogenesis in the capsule
(Figure 3B). 215
DISCUSSION
Salvage of exposed implants is a great challenge in
reconstructive surgery. Different factors may lead to
implant protrusion e.g., errors in planning, thermal and
mechanic injuries as surgical complications, smoking 220
FIGURE 2. The blood flow of capsule flaps and thoraco-epigastrial fasciocutaneous flaps. Caps.:
capsulotomy, Inc.: incision, Prep. of the flap: preparation of the flap, Fix. of the flap: fixation of
the flap. Values are referred to the baseline and are given as percentage. Median values with 25th
and 75th percentiles are demonstrated. A: blood flow of the capsule flaps in different stages of the
operation. B: perfusion of the thoraco-epigastrial fasciocutaneous flaps during different steps of
the intervention.
Journal of Investigative Surgery
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in the patient’s history or previous radiotherapy. In our
Institution, the ratio of immediate breast reconstruction
with implant comes to 41% while local complications
accompany 11.6% of these cases. Traditional therapeu-
tic approaches involve antibiotics, drainage, rinsing,225
capsulotomy, change of the device and primary clos-
ing of the wound after excision of the necrotic tissue.5-7
However, they may also fail in cases of decreased tis-
sue viability and irradiation. Implant protrusion is a
gradual process and its later stages require a more230
invasive surgical intervention.14 Several techniques
are used for the covering of implants e.g., deepithe-
lialized skin,15,16 abdominal fascial flaps,17 acellular
dermal matrix (ADM),18-21 autologous dermal graft22
and polyglycol mesh.23 If signs of inflammation are235
not detected, latissimus dorsi flaps or local perforator
flap can be applied.24,25 In cases of inflammation, the
implant should be removed and later reconstruction or
implantation of autologous fat can be chosen.8 How-
ever, these procedures may have disadvantages. ADM240
is expensive26 and its application can be accompa-
nied by seroma and infection.7,27 Furthermore, patients
often refusemore radical surgical therapies (e.g., differ-
ent flap techniques) due to the esthetic and functional
damage to the donor site, and they prefer less radical245
methods.
Capsule flaps provide a less invasive and cost-
effective solution. In animal experiments, capsules
were used to support the survival of transplanted der-
mal grafts28 as random10 or axial flaps.29,30 It has also250
been shown that capsule flaps are suitable for the cor-
rection of postimplant breast rippling31 and contour
deformities of the breast.7 Capsule flap can be obtained
from the anterior surface and also from the tissue layer
adjacent to the chest wall. Subject to localization of the255
defect and the viability of the tissue, superior, inferior,
medial or lateral flaps can be applied.10,28-30
Since sufficient blood supply is a cornerstone of tis-
sue survival, several investigations have focused on
the vascularity of capsule flaps. Some evidence has260
already indicated the appropriate blood supply of the
capsule flap. According to clinical observation, bleed-
ing of the edges when tailoring the flap indicates a
good vascularization.7 Moreover, a histological exami-
nation found angiogenesis in non-expanded capsules265
from the 4th postoperative week on, and the peak
of this process was achieved by the 8th week.32 It
is a further question whether expansion of the flap
influences the vascularization and perfusion of the tis-
sue. In expanded flaps, vessels of higher volume were270
found as compared to primer flaps, but no statisti-
cally significant differencewas detected in terms of ves-
sel density.10 In another study, the radioactive micro-
sphere technique did not reveal difference between
the blood flow of expanded and non-expanded275
flaps.33
Our results, in accordancewith findings in literature,
show that capsule flaps provide a well-vascularized
layer which prevents protrusion of the implant and
decreases tension, thereby promoting wound heal- 280
ing and reduced risk of inflammation and superin-
fection. An important novel aspect of our study is
the in vivo determination of microcirculatory status
during the operation. Laser Doppler flowmetry was
chosen for these measurements since it is an accu- 285
rate and reliable method for assessingmicrocirculatory
function.34 Our in vivo finding has confirmed that sur-
gical stress does not decrease the blood supply of flaps
which then provided an optimal ground for the healing
process. 290
In conclusion, the capsule flap seems to be appro-
priate for salvage of exposed implants and for enhance-
ment of implant cover in case of thin and injured tissue.
Capsule flaps are reliable, not difficult to prepare, have
good circulation and may therefore play an important 295
role in reconstructive surgery of the breast. On the other
hand, capsule flaps shall not be applied in case of seri-
ous inflammation and large tissue defect. Moreover,
the number of published cases of breast reconstruc-
tion with capsule flaps is relatively low.7 Hence, more 300
experience with the technique may be needed before
widespread adaptation.
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